ICU Glucose Target NICE-SUGAR — FRCA Final MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: D — 6.0-10.0 mmol/L
The NICE-SUGAR trial (2009) demonstrated that intensive glucose control (4.5-6.0 mmol/L) in critically ill patients increased mortality compared to conventional control (≤10.0 mmol/L). This landmark trial reversed previous practice based on the Leuven study. Current SSC guidelines (2021) and ICS standards recommend targeting blood glucose ≤10.0 mmol/L (typically 6-10 mmol/L range), using insulin infusion when glucose exceeds 10 mmol/L, and avoiding hypoglycaemia (<4.0 mmol/L) which independently increases mortality.
Reference: NICE-SUGAR Investigators – 2009 – NEJM; SSC – 2021 – International guidelines; ICS – 2023 – ICU nutrition